Summary Significant Accounting Policies Parentheticals (Details) (USD $)
|
9 Months Ended | |
---|---|---|
Sep. 30, 2013
|
Sep. 30, 2012
|
|
Summary Significant Accounting Policies Parentheticals | ||
Amortization of deferred financing costs related to convertible debt | $ 13,015 | $ 72,154 |
Costs of patents written off (ProAlgaZyme) | 6,234 | |
Intellectual property | 1,391,281 | |
Research Expenses - Salaries and equipment related expenses | 30,351 | 102,440 |
Clinical Studies expenses - fees, charges and related expenses | 680,825 | 441,490 |
Compensation expenses recorded | 360,103 | 34,935 |
Advertising/Public Relation costs charged to operating expenses | $ 27,551 | $ 22,289 |
X | ||||||||||
- Definition
Advertising/Public Relation costs charged to operating expenses No definition available.
|
X | ||||||||||
- Definition
Amortization of deferred financing costs related to convertible debt No definition available.
|
X | ||||||||||
- Definition
Clinical Studies expenses - fees, charges and related expenses No definition available.
|
X | ||||||||||
- Definition
Compensation expenses recorded No definition available.
|
X | ||||||||||
- Definition
Costs of patents written off (ProAlgaZyme) No definition available.
|
X | ||||||||||
- Definition
Intellectual property acquired No definition available.
|
X | ||||||||||
- Definition
Research Expenses - Salaries and equipment related expenses No definition available.
|
X | ||||||||||
- Details
|